Nvidia expects to be allowed to resume China sales of H20 GPUs, Bloomberg says
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
2 minutes ago
- Bloomberg
ASML CFO Says Easing China AI Chip Controls Would Boost Demand
ASML Holding NV Chief Financial Officer Roger Dassen said on an earnings call Wednesday it will be 'positive for chip demand' if Washington lifts restrictions on some artificial intelligence processors. This week Nvidia Corp. said it received assurances that the US government will allow the export of some chips to the Asian nation that had previously been blocked. Advanced Micro Devices Inc., Nvidia's chief rival, followed with a similar announcement.
Business Insider
11 minutes ago
- Business Insider
UnitedHealth Stock (UNH) Down as $3.3B Secret Sales Raise Eyebrows
UnitedHealth Group (UNH) is facing questions about how it maintained its streak of over 60 consecutive quarterly earnings beats. According to a Bloomberg report, the healthcare giant quietly sold stakes in some business units to firms like Warburg Pincus and KKR (KKR), generating $3.3 billion in profit that helped it beat Q424 estimates. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. UNH stock was down over 2% during Tuesday's regular trading session as investors reacted to the company's accounting move and looked ahead to its Q225 earnings report on July 29. The Deals That Boosted Profits At the end of 2024, UnitedHealth was facing rising medical costs and regulatory pressures that were hurting profits. The company then offset this by making the last-minute asset sales to private equity firms. Without the asset sales, UNH would have missed earnings for the first time in over 15 years. Thus, UNH added the gains to its adjusted earnings, which helped it report adjusted EPS of $6.81 in Q4 and beat the forecast by $0.07. UNH's Unusual Accounting Practices It must be noted that UNH left out a $7.1 billion loss from its Brazil exit, calling it a one-time event, but included the $3.3 billion gain from U.S. asset sales in its core earnings. Analysts say that's allowed under U.S. rules, though some called it 'unusual' and said the earnings were low-quality and non-recurring. This new finding adds to the growing list of challenges UnitedHealth is already facing. The company is under criminal investigation by the DOJ for alleged Medicare billing irregularities. In May, CEO Andrew Witty abruptly resigned, replaced by former CEO Stephen Hemsley, to lead the company as it deals with growing regulatory pressure. Is UNH a Good Buy Right Now? Turning to Wall Street, UNH stock has a Moderate Buy consensus rating based on 18 Buys, seven Holds, and one Sell assigned in the last three months. At $357.14, the average UnitedHealth stock price target implies a 21.54% upside potential.
Business Insider
30 minutes ago
- Business Insider
RBC Capital Sticks to Its Buy Rating for Eiffage (0NPT)
In a report released on July 14, Ruairi Cullinane from RBC Capital maintained a Buy rating on Eiffage, with a price target of €135.00. The company's shares closed last Monday at €117.73. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Cullinane covers the Industrials sector, focusing on stocks such as International Consolidated Airlines, EasyJet, and Firstgroup. According to TipRanks, Cullinane has an average return of 10.5% and a 60.54% success rate on recommended stocks. Eiffage has an analyst consensus of Strong Buy, with a price target consensus of €140.83, representing a 19.62% upside. In a report released on July 2, Jefferies also maintained a Buy rating on the stock with a €136.00 price target.
